[go: up one dir, main page]

SE8702562L - Nya fibrinolytiska enzymer - Google Patents

Nya fibrinolytiska enzymer

Info

Publication number
SE8702562L
SE8702562L SE8702562A SE8702562A SE8702562L SE 8702562 L SE8702562 L SE 8702562L SE 8702562 A SE8702562 A SE 8702562A SE 8702562 A SE8702562 A SE 8702562A SE 8702562 L SE8702562 L SE 8702562L
Authority
SE
Sweden
Prior art keywords
plasminogen activator
domain
fibrinolytically active
deleted
dna
Prior art date
Application number
SE8702562A
Other languages
English (en)
Other versions
SE8702562D0 (sv
Inventor
G Pohl
L Hansson
B Loewenadler
Original Assignee
Kabigen Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabigen Ab filed Critical Kabigen Ab
Priority to SE8702562A priority Critical patent/SE8702562L/sv
Publication of SE8702562D0 publication Critical patent/SE8702562D0/sv
Priority to DE8888850207T priority patent/DE3883315D1/de
Priority to EP88850207A priority patent/EP0297066B1/en
Priority to AT88850207T priority patent/ATE93273T1/de
Priority to JP63149893A priority patent/JP2628345B2/ja
Priority to CA000569728A priority patent/CA1341459C/en
Priority to DK335488A priority patent/DK335488A/da
Priority to AU17789/88A priority patent/AU615450B2/en
Publication of SE8702562L publication Critical patent/SE8702562L/sv
Priority to US08/653,104 priority patent/US6682733B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
SE8702562A 1987-06-18 1987-06-18 Nya fibrinolytiska enzymer SE8702562L (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE8702562A SE8702562L (sv) 1987-06-18 1987-06-18 Nya fibrinolytiska enzymer
DE8888850207T DE3883315D1 (de) 1987-06-18 1988-06-14 Neue fibrinolytische enzyme.
EP88850207A EP0297066B1 (en) 1987-06-18 1988-06-14 Novel fibrinolytic enzymes
AT88850207T ATE93273T1 (de) 1987-06-18 1988-06-14 Neue fibrinolytische enzyme.
JP63149893A JP2628345B2 (ja) 1987-06-18 1988-06-17 新規な線維素溶解酵素
CA000569728A CA1341459C (en) 1987-06-18 1988-06-17 Modified fibrinolytic enzymes
DK335488A DK335488A (da) 1987-06-18 1988-06-17 Fibrinolytisk aktivt enzym
AU17789/88A AU615450B2 (en) 1987-06-18 1988-06-17 Novel fibrinolytic enzymes
US08/653,104 US6682733B1 (en) 1987-06-18 1996-05-24 Fibrinolytic enzymes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8702562A SE8702562L (sv) 1987-06-18 1987-06-18 Nya fibrinolytiska enzymer

Publications (2)

Publication Number Publication Date
SE8702562D0 SE8702562D0 (sv) 1987-06-18
SE8702562L true SE8702562L (sv) 1988-12-19

Family

ID=20368916

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702562A SE8702562L (sv) 1987-06-18 1987-06-18 Nya fibrinolytiska enzymer

Country Status (8)

Country Link
EP (1) EP0297066B1 (sv)
JP (1) JP2628345B2 (sv)
AT (1) ATE93273T1 (sv)
AU (1) AU615450B2 (sv)
CA (1) CA1341459C (sv)
DE (1) DE3883315D1 (sv)
DK (1) DK335488A (sv)
SE (1) SE8702562L (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5094953A (en) * 1988-03-21 1992-03-10 Genentech, Inc. Human tissue plasminogen activator variants
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5258180A (en) * 1988-09-02 1993-11-02 Genetech, Inc. Tissue plasminogen activator having fibrin specific properties and deletion of amino acids 466-970, compositions and methods of treatment
DE3903581A1 (de) * 1989-02-07 1990-08-16 Boehringer Mannheim Gmbh Gewebs-plasminogenaktivator-derivat
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5595736A (en) * 1991-04-22 1997-01-21 Eli Lilly And Company Compounds and methods for treatment of thromboembolic disorders
WO1993024635A1 (en) * 1992-06-03 1993-12-09 Genentech, Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
KR100728916B1 (ko) * 2005-11-15 2007-06-14 권영두 타이밍벨트 및 그 결합구조

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61247384A (ja) * 1984-10-18 1986-11-04 チモ−ジエネテイツクス　インコ−ポレ−テツド 酵母中でプラスミノ−ゲン活性化因子を発現する方法
ES8801374A1 (es) * 1985-04-04 1988-01-01 Beecham Group Plc Un procedimiento para preparar un activante de plasminogeno.
NZ217331A (en) * 1985-08-26 1989-05-29 Lilly Co Eli Tissue plasminogen activator derivatives and genetically engineered product
JPH0811066B2 (ja) * 1985-09-30 1996-02-07 インテグレーテッド・ジエネティックス・インコーポレーテッド 組換えｄｎａが生産するヒト子宮プラスミノ−ゲンアクチベ−タ−
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
KR950000303B1 (ko) * 1985-12-20 1995-01-13 디 엎죤 캄파니 조직 플라스미노겐 활성화 인자(tpa) 상사체를 제조하는 방법
ATE74379T1 (de) * 1985-12-23 1992-04-15 Chiron Corp Peptidplasminogenaktivatoren.
DE3789664T3 (de) * 1986-01-31 2004-09-16 Genetics Institute, LLC, Cambridge Neue thrombolytische proteine.
EP0234051B1 (en) * 1986-02-17 1991-12-11 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis Tissue-type plasminogen activator mutants; recombinant genetic information coding therefor and process for preparing said mutants; their use and pharmaceutical compositions
AU7090687A (en) * 1986-04-02 1987-10-08 Beecham Group Plc Modified tissue-type plasminogen activators
GB8608020D0 (en) * 1986-04-02 1986-05-08 Beecham Group Plc Compounds
DK345087A (da) * 1986-07-11 1988-01-12 Novo Industri As Modificeret vaevsplasminogenaktivator
GB8701811D0 (en) * 1987-01-28 1987-03-04 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
ATE93273T1 (de) 1993-09-15
DE3883315D1 (de) 1993-09-23
JP2628345B2 (ja) 1997-07-09
SE8702562D0 (sv) 1987-06-18
EP0297066A1 (en) 1988-12-28
DK335488A (da) 1988-12-19
AU1778988A (en) 1988-12-22
AU615450B2 (en) 1991-10-03
JPH02436A (ja) 1990-01-05
DK335488D0 (da) 1988-06-17
CA1341459C (en) 2004-10-19
EP0297066B1 (en) 1993-08-18

Similar Documents

Publication Publication Date Title
HU896005D0 (en) Process for producing plasminogen activator (t-pa) zymogenes of tissues and preparatives containing such active substances
ATE70301T1 (de) Gewebeplasminogen-aktivator-mutant, dafuer kodierende rekombinante genetische information und verfahren zur herstellung dieser mutanten, deren verwendung und pharmazeutische zusammensetzungen.
ATE85081T1 (de) Analoge des gewebespezifischen plasminogenaktivators.
SE8702562L (sv) Nya fibrinolytiska enzymer
DK0506791T3 (da) Enzymholdigt præparat og detergent indeholdende et sådant præparat
KR890003952A (ko) 신규 조직 플라스미노겐 활성제
PT94680A (pt) Processo para a obtencao de uma proteina tendo actividade de urato oxidase gene recombinante que a codifica vector de expressao portador deste gene microorganismos procariotas e celulas eucariotas transformados por este vector de expressao
NO179754C (no) Fremgangsmåte for fremstilling av en t-PA-analog, DNA-sekveks som koder for t-PA-analogen, ekspresjonsvektor omfattende DNA-sekvensen samt vertscelle omfattende denne
IL90146A0 (en) Variants of plasminogen activators and processes for their production
DE3888386D1 (de) Verfahren zur Herstellung von Proteinen.
KR890701733A (ko) 신규 인체 조직형 플리스미노겐 활성제 변이체
DK0517756T3 (da) Vævs-plasminogenaktivator med fibrinspecifikke egenskaber
ES2056123T3 (es) Clonacion del gen que codifica la enzima isoamilasa y su empleo en la produccion de dicha enzima.
DE69113049D1 (de) Varianten des gewebeplasminogenaktivators mit vermindertem abbau.
GR3015094T3 (en) Tissue plasminogen activator substitution variant.
EP0381331A3 (en) Gene sequences encoding modified residues situated in the protease domain of tpa
JPS6474986A (en) Protease and a novel microorganism producing the same

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8702562-3

Effective date: 19920709

Format of ref document f/p: F